Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes

被引：0
|
作者：
Saito, Rie [1 ]
Harada, Norio [1 ]
机构：
[1] Univ Fukui, Sch Med Sci, Dept Endocrinol & Metab, 23-3 Matsuoka Shimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
来源：
DIABETOLOGY INTERNATIONAL | 2024年
关键词：
Incretin; GIP; GLP-1; Incretin effect; Insulin secretion; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; NON-ASIANS; SECRETION; TOLERANCE; MELLITUS; EFFICACY; GLP-1; GIP;
D O I：
10.1007/s13340-024-00781-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gastrointestinal hormones that potentiate insulin secretion from pancreatic beta-cells are called incretins. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the major incretins. Incretin-mediated stimulation of insulin secretion (incretin effect) plays an important role in lowering postprandial blood-glucose levels. Incretin effect is reduced under diabetic condition. Several mechanisms have been reported for the reduction of incretin effect. Incretin-related drugs are used worldwide for the treatment of type 2 diabetes. In addition, several new incretin-related drugs have been developed and are expected to be available in clinical practice.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Incretins: a new treatment option for type 2 diabetes?
    Geelhoed-Duijvestijn, P. H. L. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (02): : 60 - 64
  • [2] Effects of type 2 diabetes on the regulation of hepatic glucose metabolism
    Basu, A
    Shah, P
    Nielsen, M
    Basu, R
    Rizza, RA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (06) : 366 - 374
  • [3] The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
    Kim, Wook
    Egan, Josephine M.
    PHARMACOLOGICAL REVIEWS, 2008, 60 (04) : 470 - 512
  • [4] The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity
    Karras, Spyridon
    Goulis, Dimitrios G.
    Mintziori, Gesthimani
    Katsiki, Niki
    Tzotzas, Themistoklis
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 781 - 791
  • [5] INNOVATIONS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: USE OF INCRETINS
    Dedov, I. I.
    Shestakova, M. V.
    Sukhareva, O. Yu
    TERAPEVTICHESKII ARKHIV, 2010, 82 (10) : 5 - 10
  • [6] Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes
    Ivy C. Mason
    Jingyi Qian
    Gail K. Adler
    Frank A. J. L. Scheer
    Diabetologia, 2020, 63 : 462 - 472
  • [7] Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes
    Mason, Ivy C.
    Qian, Jingyi
    Adler, Gail K.
    Scheer, Frank A. J. L.
    DIABETOLOGIA, 2020, 63 (03) : 462 - 472
  • [8] Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
    Rines, Amy K.
    Sharabi, Kfir
    Tavares, Clint D. J.
    Puigserver, Pere
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 786 - 804
  • [9] Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
    Amy K. Rines
    Kfir Sharabi
    Clint D. J. Tavares
    Pere Puigserver
    Nature Reviews Drug Discovery, 2016, 15 : 786 - 804
  • [10] Relevance of incretins in the treatment of Asian patients with Type 2 diabetes
    Seino, Yutaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S4 - S4
12345